Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) saw a large decrease in short interest in April. As of April 15th, there was short interest totalling 280,500 shares, a decrease of 18.1% from the March 31st total of 342,600 shares. Based on an average daily trading volume, of 63,900 shares, the days-to-cover ratio is currently 4.4 days. Currently, 0.9% of the shares of the stock are sold short.

Institutional Investors Weigh In On Bioceres Crop Solutions

Hedge funds have recently added to or reduced their stakes in the stock. Polar Capital Holdings Plc bought a new stake in Bioceres Crop Solutions during the 3rd quarter worth about $2,112,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in Bioceres Crop Solutions by 46.7% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 136,635 shares of the company's stock worth $1,876,000 after acquiring an additional 43,484 shares during the last quarter. Ballast Asset Management LP bought a new stake in Bioceres Crop Solutions during the 3rd quarter worth about $2,210,000. Raymond James & Associates grew its holdings in Bioceres Crop Solutions by 4.9% during the 3rd quarter. Raymond James & Associates now owns 27,567 shares of the company's stock worth $311,000 after acquiring an additional 1,300 shares during the last quarter. Finally, Federated Hermes Inc. boosted its stake in shares of Bioceres Crop Solutions by 8.5% in the 3rd quarter. Federated Hermes Inc. now owns 141,684 shares of the company's stock valued at $1,600,000 after purchasing an additional 11,057 shares during the last quarter. Institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Price Performance

Shares of Bioceres Crop Solutions stock traded down $0.03 during mid-day trading on Friday, reaching $12.05. 50,913 shares of the stock were exchanged, compared to its average volume of 27,631. The company has a market cap of $756.70 million, a price-to-earnings ratio of 37.66 and a beta of 0.58. The company has a current ratio of 1.24, a quick ratio of 0.84 and a debt-to-equity ratio of 0.33. The firm has a 50-day simple moving average of $12.72 and a 200 day simple moving average of $12.55. Bioceres Crop Solutions has a fifty-two week low of $9.76 and a fifty-two week high of $14.20.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last announced its earnings results on Thursday, February 8th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.07 by $0.02. The business had revenue of $140.30 million during the quarter, compared to analysts' expectations of $108.97 million. Bioceres Crop Solutions had a net margin of 4.36% and a return on equity of 5.96%. During the same quarter last year, the company posted ($0.14) EPS. On average, sell-side analysts predict that Bioceres Crop Solutions will post 0.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Roth Mkm increased their price objective on shares of Bioceres Crop Solutions from $20.00 to $21.00 and gave the company a "buy" rating in a research note on Friday, February 9th.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.